Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Collins

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
The American Journal of Pathology|February 25, 2003
High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarraysPamela L Paris, Donna G Albertson, Janneke C Alers, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2023
A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing SarcomaLouise Ramos, Sarah Truong, Beibei Zhai, et al.
Molecular Cancer Therapeutics|May 2, 2006
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panelKimberly J Bussey, Koei Chin, Samir Lababidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repairAlan Dal Pra, Emilie Lalonde, Jenna Sykes, et al.
Genome Research|February 8, 2006
Decoding the fine-scale structure of a breast cancer genome and transcriptomeStanislav Volik, Benjamin J Raphael, Guiqing Huang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Longitudinal single-cell analysis reveals RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiationYuchao Ni, Dong Lin, Mingchen Shi, et al.
Molecular Cancer Research : MCR|January 27, 2022
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical ImplicationsXin Dong, Hui Xue, Fan Mo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Oncotarget|February 2, 2017
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistanceMannan Nouri, Josselin Caradec, Amy Anne Lubik, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
The American Journal of Pathology|February 25, 2003
High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarraysPamela L Paris, Donna G Albertson, Janneke C Alers, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2023
A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing SarcomaLouise Ramos, Sarah Truong, Beibei Zhai, et al.
Molecular Cancer Therapeutics|May 2, 2006
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panelKimberly J Bussey, Koei Chin, Samir Lababidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repairAlan Dal Pra, Emilie Lalonde, Jenna Sykes, et al.
Genome Research|February 8, 2006
Decoding the fine-scale structure of a breast cancer genome and transcriptomeStanislav Volik, Benjamin J Raphael, Guiqing Huang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Longitudinal single-cell analysis reveals RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiationYuchao Ni, Dong Lin, Mingchen Shi, et al.
Molecular Cancer Research : MCR|January 27, 2022
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical ImplicationsXin Dong, Hui Xue, Fan Mo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Oncotarget|February 2, 2017
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistanceMannan Nouri, Josselin Caradec, Amy Anne Lubik, et al.
Pageof 9